Drug Hunting
Strategic navigation of biopharmaceutical pipelines to identify, evaluate, and acquire promising drug candidates for development.
Key Capabilities
- Navigation of the current and future pipeline of the top ten biopharmaceutical companies
- Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
- Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
- Investor backed drug acquisition and development through proof-of-concept
- Comprehensive competitive landscape analysis
- Target product profile (TPP) development and assessment
- Risk-benefit analysis for pipeline candidates
Our Approach
Bionavigen's Drug Hunting service leverages 30+ years of industry experience to systematically identify and evaluate drug candidates from major pharmaceutical pipelines. Our team applies deep scientific knowledge combined with strategic intelligence to uncover high-value opportunities.
We work closely with VC investment firms and biotech companies to provide rigorous due diligence on potential out-licensing candidates, ensuring that investment decisions are grounded in sound scientific and clinical rationale.
Our approach emphasizes finding candidates with differentiated mechanisms, novel indications, or innovative combination strategies that can maximize clinical and commercial success.